Abstract
Target product profiles (TPPs) are used as a regulatory tool for dialog on clinical development or manufacturing plans. Drugs and biologics approved by the FDA that mention TPPs are associated with more efficient regulatory review times, perhaps as a result of increased planning or because the TPP promotes well-organized regulatory dialog.
Original language | English (US) |
---|---|
Pages (from-to) | 576-579 |
Number of pages | 4 |
Journal | Trends in Biotechnology |
Volume | 35 |
Issue number | 7 |
DOIs |
|
State | Published - Jul 2017 |
Keywords
- product development
- target product profile
- time to market
ASJC Scopus subject areas
- Biotechnology
- Bioengineering